Skip to main content
. 2018 Nov 6;7(11):418. doi: 10.3390/jcm7110418

Table 3.

Clinical presentation of cancer patients with systemic capillary leak syndrome.

Clinical Presentation Observed Number of Patients (%)
among Total Number of Patients (n = 62)
General condition
Edema 42 (67.7%)
Weight gain 13 (21.0%)
Malaise 5 (8.1%)
General weakness 3 (4.8%)
Skin rash 4 (6.4%)
Hot flushing 1 (1.6%)
Sweating 1 (1.6%)
Gum hypertrophy 1 (1.6%)
Weight loss 1 (1.6%)
Disturbance of consciousness 1 (1.6%)
Inflammation-related
Fever 11 (17.7%)
Lymph node enlargement 3 (4.8%)
Otalgia 1 (1.6%)
Pulmonary
Dyspnea 17 (27.4%)
Pleural effusion 18 (29.0%)
Pulmonary edema 7 (11.3%)
Tachypnea 5 (8.1%)
Hypoxemia 4 (6.4%)
Pulmonary hypertension 1 (1.6%)
Cardiovascular
Hypotension 20 (32.2%)
Hypertension 3 (4.8%)
Pericardial effusion 6 (9.7%)
Tachycardia 5 (8.1%)
Bradycardia 1 (1.6%)
Chest pain 1 (1.6%)
Syncope 1 (1.6%)
Decreased exercise tolerance 1 (1.6%)
Pericarditis 1 (1.6%)
Gastrointestinal
Ascites 14 (22.7%)
Nausea 3 (4.8%)
Vomiting 4 (6.4%)
Abdominal distention 3 (4.8%)
Diarrhea 2 (3.2%)
Hepatosplenomegaly 1 (1.6%)
Renal
Oliguria 14 (22.7%)
Proteinuria 1 (1.6%)
Neurologic
Dizziness 1 (1.6%)
Back discomfort 1 (1.6%)
Tremor 1 (1.6%)
Paresthesia 1 (1.6%)